AIMS: This study was designed to evaluate the effects of the Na(+)/Ca(2+) exchange (NCX) inhibitor SEA0400 on Ca(2+) handling in isolated canine ventricular myocytes. METHODS AND RESULTS: Intracellular Ca(2+) ([Ca(2+)](i)) transients, induced by either field stimulation or caffeine flush, were monitored using Ca(2+) indicator dyes. [Ca(2+)](i)-dependent modulation of the inhibitory effect of SEA0400 on NCX was characterized by the changes in Ni(2+)-sensitive current in voltage-clamped myocytes. Sarcoplasmic reticulum (SR) Ca(2+) release and uptake were studied in SR membrane vesicles. Gating properties of single-ryanodine receptors were analysed in lipid bilayers. Ca(2+) sensitivity of the contractile machinery was evaluated in chemically skinned myocytes. In myocytes paced at 1 Hz, neither diastolic [Ca(2+)](i) nor the amplitude of [Ca(2+)](i) transients was significantly altered by SEA0400 up to the concentration of 1 microM, which was shown to inhibit the exchange current. The blocking effect of SEA0400 on NCX decreased with increasing [Ca(2+)](i), and it was more pronounced in reverse than in forward mode operation at every [Ca(2+)](i) examined. The rate of decay of the caffeine-induced [Ca(2+)](i) transients was decreased significantly by 1 microM SEA0400; however, this effect was only a fraction of that observed with 10 mM NiCl(2). Neither SR Ca(2+) release and uptake nor cell shortening and Ca(2+) sensitivity of the contractile proteins were influenced by SEA0400. CONCLUSION: The lack of any major SEA0400-induced shift in Ca(2+) transients or contractility of myocytes can well be explained by its limited inhibitory effect on NCX (further attenuated by elevated [Ca(2+)](i) levels) and a concomitant reduction in Ca(2+) influx due to the predominantly reverse mode blockade of NCX and suppression of L-type Ca(2+) current.
AIMS: This study was designed to evaluate the effects of the Na(+)/Ca(2+) exchange (NCX) inhibitor SEA0400 on Ca(2+) handling in isolated canine ventricular myocytes. METHODS AND RESULTS: Intracellular Ca(2+) ([Ca(2+)](i)) transients, induced by either field stimulation or caffeineflush, were monitored using Ca(2+) indicator dyes. [Ca(2+)](i)-dependent modulation of the inhibitory effect of SEA0400 on NCX was characterized by the changes in Ni(2+)-sensitive current in voltage-clamped myocytes. Sarcoplasmic reticulum (SR) Ca(2+) release and uptake were studied in SR membrane vesicles. Gating properties of single-ryanodine receptors were analysed in lipid bilayers. Ca(2+) sensitivity of the contractile machinery was evaluated in chemically skinned myocytes. In myocytes paced at 1 Hz, neither diastolic [Ca(2+)](i) nor the amplitude of [Ca(2+)](i) transients was significantly altered by SEA0400 up to the concentration of 1 microM, which was shown to inhibit the exchange current. The blocking effect of SEA0400 on NCX decreased with increasing [Ca(2+)](i), and it was more pronounced in reverse than in forward mode operation at every [Ca(2+)](i) examined. The rate of decay of the caffeine-induced [Ca(2+)](i) transients was decreased significantly by 1 microM SEA0400; however, this effect was only a fraction of that observed with 10 mM NiCl(2). Neither SR Ca(2+) release and uptake nor cell shortening and Ca(2+) sensitivity of the contractile proteins were influenced by SEA0400. CONCLUSION: The lack of any major SEA0400-induced shift in Ca(2+) transients or contractility of myocytes can well be explained by its limited inhibitory effect on NCX (further attenuated by elevated [Ca(2+)](i) levels) and a concomitant reduction in Ca(2+) influx due to the predominantly reverse mode blockade of NCX and suppression of L-type Ca(2+) current.
Authors: Lin Xu; Christiana S Kappler; Santhosh K Mani; Neal R Shepherd; Ludivine Renaud; Paige Snider; Simon J Conway; Donald R Menick Journal: J Biol Chem Date: 2009-08-06 Impact factor: 5.157
Authors: Norbert Szentandrássy; Péter Birinyi; Gyula Szigeti; Attila Farkas; János Magyar; András Tóth; László Csernoch; András Varró; Péter P Nánási Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2008-05-06 Impact factor: 3.000
Authors: Norbert Nagy; Anita Kormos; Zsófia Kohajda; Áron Szebeni; Judit Szepesi; Piero Pollesello; Jouko Levijoki; Károly Acsai; László Virág; Péter P Nánási; Julius Gy Papp; András Varró; András Tóth Journal: Br J Pharmacol Date: 2014-12 Impact factor: 8.739
Authors: Joachim Seegers; Marc A Vos; Panagiota Flevari; Rik Willems; Christian Sohns; Dirk Vollmann; Lars Lüthje; Dimitrios T Kremastinos; Vincent Floré; Mathias Meine; Anton Tuinenburg; Rachel C Myles; Dirk Simon; Jürgen Brockmöller; Tim Friede; Gerd Hasenfuß; Stephan E Lehnart; Markus Zabel Journal: Europace Date: 2011-11-23 Impact factor: 5.214
Authors: János Prorok; Péter P Kovács; Attila A Kristóf; Norbert Nagy; Dóra Tombácz; Judit S Tóth; Balázs Ordög; Norbert Jost; László Virág; Julius G Papp; András Varró; András Tóth; Zsolt Boldogkoi Journal: J Biomed Biotechnol Date: 2009-07-14
Authors: Djemail Ismaili; Katrin Gurr; András Horváth; Lei Yuan; Marc D Lemoine; Carl Schulz; Jascha Sani; Johannes Petersen; Hermann Reichenspurner; Paulus Kirchhof; Thomas Jespersen; Thomas Eschenhagen; Arne Hansen; Jussi T Koivumäki; Torsten Christ Journal: Cells Date: 2022-08-05 Impact factor: 7.666
Authors: Nils Bögeholz; Jan S Schulte; Sven Kaese; B Klemens Bauer; Paul Pauls; Dirk G Dechering; Gerrit Frommeyer; Joshua I Goldhaber; Uwe Kirchhefer; Lars Eckardt; Christian Pott; Frank U Müller Journal: Front Pharmacol Date: 2017-09-21 Impact factor: 5.810